Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization 2021 - 2025" report has been added to ResearchAndMarkets.com's offering.
How will COVID-19 affect Syndromic and Infectious Disease Diagnostics?
The COVID pandemic is ushering in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician's Office or even the Home?
Syndromic testing is proving itself in the market. Players are reporting double-digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.
The report forecasts the market size out to 2024. In a special section the report looks at the numbers on how syndromic molecular diagnostics is replacing traditional panel-based ordering of infectious disease tests.
Factors Driving Growth
Speed of Diagnosis
Effect of Syndromic Testing on Costs.
Point of Care Advantage.
Syndrome Testing, Accuracy and Diagnostic Risk
Improvement in Outcomes.
Impact of the COVID-19 Pandemic.
Factors Limiting Growth
Infectious Disease is Declining But..
Economic Growth improves Living Standards
Impact of the Pandemic Recession
Instrumentation and Automation
Instruments Key to Market Share
The Shrinking Machine
Syndrome Testing Moving to Big Instruments?
Diagnostic Technology Development
Comparing Syndrome and Targeted Testing
The Multiplex Paradigm Shift
The Sepsis Testing Market - Bellwether for Syndromics
The Single Visit and AntiMicrobial Resistance
Syndromics drives POCT adoption
A Big Future for PCR?
Syndromic Testing Recent Developments
Recent Developments - Importance and How to Use This Section
Importance of These Developments
How to Use This Section
Scanogen's Portable Battery Operated Instrument for 90 Minute Multiplex Test
Qiagen sees NeuMoDx as Growth Vehicle
Torus Biosystems Developing Syndromic Test with 30-Minute Turnaround
Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests
BioMerieux's BioFire SARS-CoV-2 Respiratory Panel Wins FDA EAU
Infectious Disease Testing Firm Curative Acquires KorvaLabs
ChromaCode Raises Additional $10M
COVID-19 Patients Need Syndromic Testing
GenMark Diagnostics - New Respiratory Panel due in June
Qiagen Respiratory Panel with Coronavirus Targets Receives CE Mark
Exact Diagnostics launches respiratory panel control
bioMerieux submits enhanced BIOFIRE BCID2 Panel to FDA
Nanomix Receives CE Mark for Diagnostic
Applied BioCode Applies to FDA for Syndromic Respiratory Panel
Expedeon AG and Sona Nanotech to Collaborate on Multiplex POC
QIAGEN's New GI Panel Performance Assessed
McKesson to Distribute QIAstat-Dx Syndromic Testing Solution in USA
Applied BioCode Obtains FDA Clearance
Meridian Bioscience to Acquire GenePOC Inc
Curetis Introduces Rapid DNA Testing for Antibiotic Resistance
Qiagen gets FDA clearance for syndromic testing system
Entasis Therapeutics Signs Rapid Diagnostic Agreement with bioMerieux
Akonni Biosystems Submits Multiplex Diagnostics System to FDA
Ador Diagnostic to receive $30M in Funding for 100-Plex PoC
SAW Diagnostics Receives Funding for Commercialisation of PoC Platform
QuantuMDx and Molbio announce MoU
Immunexpress Wins $745K Contract for Rapid Sepsis Assay
Mobidiag Inks European, Middle Eastern Distribution Deals
BIOFIRE FILMARRAY System chosen for Phase 3 clinical trial
Profiles of Key Syndromic Testing Companies
Abbott Diagnostics (Alere)
Bosch Healthcare Solutions GmbH
Roche Molecular Diagnostics
Siemens Healthineers (Fast Track Diagnostics)
For more information about this report visit https://www.researchandmarkets.com/r/3c0pjh
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900